University of Duisburg-Essen
Also known as: Amir Abbas Mahabadi | AOK Hessen | AOK Rhineland / Hamburg | Cardiac Clinic, University of Essen, Germany | Department of Hematology, University Hospital Essen | Department of Hematology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany | Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Germany | Department of Internal Medicine West German Cancer Centre University Hospital Essen Essen, Germany | Department of Neurology, University Essen | Department of Nuclear Medicine, Essen University Hospital | Department of Pediatric Hematology & Oncology, Pediatrics III, University Children's Hospital Essen | Department of Psychiarty, Charite Campus Mitte, Berlin, and Department of Psychiatry, Kliniken Essen-Mitte, Essen, Germany | Department of Thoracic and Cardiovascular Surgery, West-German Heart Center, University Duisburg-Essen, Essen, Germany | Director of the Urological Clinic of the University Hospital Essen | Essen University | Essen University Hospital | Herzzentrum Duisburg | Herzzentrum Duisburg, Duisburg, Germany | Jan Ellermeier | Kliniken Essen-Mitte | Klinikum Essen Mitte | Klinken Essen-Mitte Evang. Huyssens-Stiftung | Medical University, Duisburg-Essen | Medical University, Duisburg-Essen, Germany | Medizentrum Essen-Borbeck | Prof. Dr. med. Dirk Schadendorf | Universiity Clinic Essen, Department of Nuclear Medicine | Universitaetsklinikum Essen | Universitaetsklinikum Essen, Germany | Universital hospital essen | Universital Hospital, Essen | Universität Duisburg-Essen | Universitatsklinikum der GHS Essen | Universitätsklinikum Essen | University Duisburg-Essen | University Duisburg-Essen, Chair of Integrative Gastroenterology | University Hospital Essen | University Hospital, Essen | University of Duisburg-Essen Medical School | University of Essen | West German Cancer Center - University Hospital Essen, University Duisburg-Essen
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1996Last known activity
Nov 6, 2024
Timeline
1650s
- Jan 1, 1654
University of Duisburg-Essen— Founded
Drugs by trial phase (115 distinct, 90 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (46 own, 0 via acquisition)
Phase 2 (46 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (12 own, 0 via acquisition)
Indications
Studied for
- Acromegaly
- Adenocarcinoma
- Aggression
- Alcoholism
- Alzheimer Disease
- Anemia, Aplastic
- Anemia, Hemolytic, Autoimmune
- Astrocytoma
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ductal, Breast
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinosarcoma
- Central Nervous System Neoplasms
- Cluster Headache
- Colorectal Neoplasms
- Coronary Artery Disease
- Coronary Disease
- Coronary Restenosis
- Cough
- Cystic Fibrosis
- Dementia
- Dyspepsia
- Ependymoma
- Esophageal Neoplasms
- Familial Primary Pulmonary Hypertension
- Fibrosis
- Ganglion Cysts
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Graves Disease
- Graves Ophthalmopathy
- Headache
- Head and Neck Neoplasms
- Hemangiosarcoma
- Hodgkin Disease
- Hypertension
- Inflammatory Breast Neoplasms
- Ischemia
- Kidney Diseases
- Leiomyosarcoma
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Medulloblastoma
- Melanoma
- Migraine Disorders
- Mixed Tumor, Mullerian
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms
- Nervous System Neoplasms
- Oligodendroglioma
- Opioid-Related Disorders
- Pneumonia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Recurrence
- Sarcoma
- Schizophrenia
- Stomach Neoplasms
- Thrombocytopenia
- Thyroid Diseases
- Thyroid Neoplasms
- Urinary Bladder Neoplasms
- Uveal Neoplasms
Recent trials (50)
- NCT06784791Lead sponsorPhase 2Nov 6, 2024
- NCT06698601Sponsor investigatorN/ASep 24, 2024
- NCT06698601Lead sponsorN/ASep 24, 2024
- NCT06698601OfficialN/ASep 24, 2024
- NCT06388369Lead sponsorPhase 1/Phase 2May 31, 2024
- NCT06364631CollaboratorPhase 3Apr 12, 2024
- NCT06132737Overall official - principal investigatorPhase 1/Phase 2Nov 7, 2023
- NCT05858437CollaboratorN/AOct 1, 2023
- NCT06057545Lead sponsorPhase 3Apr 25, 2023
- NCT05570409CollaboratorPhase 2/Phase 3Nov 3, 2022
- NCT05306041Overall official - principal investigatorPhase 2Jun 30, 2022
- NCT05122689Lead sponsorN/ANov 21, 2021
- NCT05118724Overall official - principal investigatorPhase 2Nov 15, 2021
- NCT05052099Lead sponsorPhase 1/Phase 2Oct 31, 2021
- NCT05052099Overall official - principal investigatorPhase 1/Phase 2Oct 31, 2021
Details
- Founded
- Bochum, DE Jan 1, 1654
- Last known activity
- Nov 6, 2024